循環器ジャーナル65巻4号

2017年10月発行

特集 ACSの診断と治療はどこまで進歩したのか Ⅲ．ACSの治療

NSTEMI，UAPの治療方針

著者： 齋藤佑一¹ 小林欣夫¹

所属機関： ¹千葉大学大学院医学研究院循環器内科学

ページ範囲：P.635 - P.642

Point
・NSTE-ACSは患者背景や重症度といった点において幅広い疾患概念である．
・個々の患者に対してリスクに応じた適切な治療方針を選択すべきである．
・リスクが高い症例ではより積極的に侵襲的な治療戦略をとるべきで，状況に応じて完全血行再建を検討する．

参考文献

1) Braunwald E, Morrow DA:Unstable angina:is it time for a requiem? Circulation 127:2452-2457, 2013

2) Naghavi M, Libby P, Falk E, et al:From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:PartⅠ. Circulation 108:1664-1672, 2003

3) Roffi M, Patrono C, Collet JP, et al:2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation:Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology（ESC）. Eur Heart J 37:267-315, 2016

4) Daida H, Miyauchi K, Ogawa H, et al:Management and two-year long-term clinical outcome of acute coronary syndrome in Japan:prevention of atherothrombotic incidents following ischemic coronary attack（PACIFIC）registry. Circ J 77:934-943, 2013

5) Ishihara M, Fujino M, Ogawa H, et al:Clinical Presentation, Management and Outcome of Japanese Patients With Acute Myocardial Infarction in the Troponin Era-Japanese Registry of Acute Myocardial Infarction Diagnosed by Universal Definition（J-MINUET）-. Circ J 79:1255-1262, 2015

6) Fox KA, Goodman SG, Klein W, et al:Management of acute coronary syndromes. Variations in practice and outcome;findings from the Global Registry of Acute Coronary Events（GRACE）. Eur Heart J 23:1177-1189, 2002

7) Montalescot G, Dallongeville J, Van Belle E, et al:STEMI and NSTEMI:are they so different? 1 year outcomes in acute myocardial infarction as defined by the ESC/ACC definition（the OPERA registry）. Eur Heart J 28:1409-1417, 2007

8) 日本循環器学会，日本冠疾患学会，日本胸部外科学会，他：循環器病の診断と治療に関するガイドライン（2011年度合同研究班報告）．非ST上昇型急性冠症候群の診療に関するガイドライン（2012年改訂版）．http://www.j-circ.or.jp/guideline/pdf/JCS2012_kimura_h.pdf

9) Sabatine MS, Morrow DA, Giugliano RP, et al:Implications of upstream glycoprotein Ⅱb/Ⅲa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction:a comparison of the Thrombolysis In Myocardial Infarction（TIMI）ⅢB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy（TACTICS）-TIMI 18 trial. Circulation 109:874-880, 2004

10) Fox KA, Dabbous OH, Goldberg RJ, et al:Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome:prospective multinational observational study（GRACE）. BMJ 333:1091, 2006

11) Fox KA, Clayton TC, Damman P, et al:Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data. J Am Coll Cardiol 55:2435-2445, 2010

12) Tegn N, Abdelnoor M, Aaberge L, et al:Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris（After Eighty study):an open-label randomised controlled trial. Lancet 387:1057-1065, 2016

13) Wallentin L, Lindhagen L, Ärnström E, et al:Early invasive versus non-invasive treatment in patients with non-ST-elevation acute coronary syndrome（FRISC-Ⅱ):15 year follow-up of a prospective, randomised, multicentre study. Lancet 388:1903-1911, 2016

14) Henderson RA, Jarvis C, Clayton T, et al:10-Year Mortality Outcome of a Routine Invasive Strategy Versus a Selective Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndrome:The British Heart Foundation RITA-3 Randomized Trial. J Am Coll Cardiol 66:511-520, 2015

15) Milosevic A, Vasiljevic-Pokrajcic Z, Milasinovic D, et al:Immediate Versus Delayed Invasive Intervention for Non-STEMI Patients:The RIDDLE-NSTEMI Study. JACC Cardiovasc Interv 9:541-549, 2016

16) Bonello L, Laine M, Puymirat E, et al:Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes:An Updated Meta-Analysis. JACC Cardiovasc Interv 9:2267-2276, 2016

17) Stone GW, Maehara A, Lansky AJ, et al:A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226-235, 201117) Stone GW, Maehara A, Lansky AJ, et al:A prospective natural-history study of coronary atherosclerosis. N Engl J Med 364:226-235, 2011

18) Généreux P, Palmerini T, Caixeta A, et al:Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention:the residual SYNTAX（Synergy Between PCI with Taxus and Cardiac Surgery）score. J Am Coll Cardiol 59:2165-2174, 2012

19) Garcia S, Sandoval Y, Roukoz H, et al:Outcomes after complete versus incomplete revascularization of patients with multivessel coronary artery disease:a meta-analysis of 89, 883 patients enrolled in randomized clinical trials and observational studies. J Am Coll Cardiol 62:1421-1431, 2013

20) Quadri G, D Ascenzo F, Moretti C, et al:Complete or incomplete coronary revascularization in patients with myocardial infarction and multivessel disease. A propensity score analysis from the “real life” BleeMACS（Bleeding complications in a Multicenter registry of patients discharged with diagnosis of Acute Coronary Syndrome）registry. EuroIntervention doi:10.4244/EIJ-D-16-00350, 2017

21) Wald DS, Morris JK, Wald NJ, et al:Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369:1115-1123, 2013

22) Gershlick AH, Khan JN, Kelly DJ, et al:Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease:the CvLPRIT trial. J Am Coll Cardiol 65:963-972, 2015

23) Engstrøm T, Kelbæk H, Helqvist S, et al:Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease（DANAMI-3-PRIMULTI):an open-label, randomised controlled trial. Lancet 386:665-671, 2015

24) Jang JS, Jin HY, Seo JS, et al:Meta-analysis of multivessel versus culprit-only percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome and multivessel coronary disease. Am J Cardiol 115:1027-1032, 2015

25) Sardella G, Lucisano L, Garbo R, et al:Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients:The SMILE Trial. J Am Coll Cardiol 67:264-272, 2016

26) Patel MR, Calhoon JH, Dehmer GJ, et al:ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes:A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons. J Am Coll Cardiol 69:570-591, 2017

27) Layland J, Oldroyd KG, Curzen N, et al:Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction:the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J 36:100-111, 2015

28) Hakeem A, Edupuganti MM, Almomani A, et al:Long-Term Prognosis of Deferred Acute Coronary Syndrome Lesions Based on Nonischemic Fractional Flow Reserve. J Am Coll Cardiol 68:1181-1191, 2016